US Patent 7998966 Axl kinase inhibitors
Patent 7998966 was granted and assigned to SUPERGEN, INC. on August, 2011 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7998966 Axl kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
